Skip to content

Cito CBC System

by Cytochip, Inc.

510(k) K240402

Cito CBC System is a Class II device made by Cytochip, Inc., cleared under FDA 510(k) K240402 on 3 Feb 2025, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Dual Track NumberK240402 Date3 Feb 2025ClearedStatusActive

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
GKZ
Device class
Class II
Regulation
21 CFR Part 864.5220
Advisory committee
Hematology
FDA decision
SESE Substantially Equivalent

Related clearances

cited in the FDA summary

Clearances this device's FDA summary refers to, and clearances whose summaries refer to it: a citation, not a claim of equivalence.

Cites

Source: 510k-lineage (choiben314), CC BY 4.0

Devices cleared under K240402

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K240402
UDI-DISize and differences
CitoCBC Analyzer 1110
Cytochip, Inc.
111000850063751117 —On the market

Similar devices

Other devices filed under FDA product code GKZ (Counter, Differential Cell).

Other devices from Cytochip, Inc.